Cancer Diagnostic Tests Market Trends and Developments 2016 - PowerPoint PPT Presentation

About This Presentation
Title:

Cancer Diagnostic Tests Market Trends and Developments 2016

Description:

The Report on “Cancer Diagnostic Tests Market Size, Share, Growth, Profit, Analysis, Trends and Strategy 2016" added by Research Beam Enquiry about report: – PowerPoint PPT presentation

Number of Views:31

less

Transcript and Presenter's Notes

Title: Cancer Diagnostic Tests Market Trends and Developments 2016


1
2016 Emerging Cancer Diagnostic Tests, and
Strategic Profile of Leading Reagent and
Instrument Suppliers
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE 1 (503) 894-6022E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview
  • The report presents comprehensive marketing and
    technological assessment, as well as medical
    rationale and diagnostic prospects, for the major
    categories of both circulating and cellular
    tests, such as Biochemical Markers, Oncogenes,
    Growth Factors, Hormones, Colony Stimulating
    Factors, Lymphokines, Immunohistochemical Stains
    and others.
  • The report includes an overview of the clinical
    significance and market needs for both current
    and emerging cancer diagnostic tests, as well as
    extensive listings of companies, universities and
    research centers developing or marketing new
    technologies, products, and applications. 
  • The report also presents strategic assessments of
    current and emerging suppliers of cancer
    diagnostic products, including their sales,
    product portfolios, distribution tactics,
    technological know-how, new products in RD,
    collaborative arrangements and business
    strategies. 
  • Read More At http//www.researchbeam.com/2016-em
    erging-cancer-diagnostic-tests-and-strategic-profi
    le-of-leading-reagent-and-instrument-suppliers-mar
    ket

3


Table of Content
1. Introduction 2. Tumor Marker
Classification 3. ACTH 4. Alpha-Fetoprotein
(AFP) 5. Beta-2 Microglobulin 6. CA 15-3/27.29 7.
CA 19-9 8. CA-125 9. Calcitonin 10.
Carcinoembrionic Antigen (CEA) 11. Estrogen and
Progesterone Receptors 12. Ferritin 13.
Gastrin 14. Human Chorionic Gonadotropin
(HCG) 15. Insulin 16. NSE 17. Occult Blood 18.
PAP Smear/HPV 19. Prostatic Acid Phosphatase
(PAP) 20. Prostate-Specific Antigen (PSA)
4


Table of Content
  • 21. Squamous Cell Carcinoma Antigen (SCC)
  • 22. T and B Lymphocytes
  • 23. TdT
  • 24. Thyroglobulin
  • 25. Tissue Polypeptide Antigen (TPA)
  • 26. Biochemical Tumor Markers
  • 27. Oncogenes
  • 28. Polypeptide Growth Factors
  • 29. Ectopic Hormones
  • 30. Colony Stimulating Factors
  • 31. Lymphokines
  • 32. Immunohistochemical Stains
  • 33. Emerging Tumor Markers
  • Enquire at http//www.researchbeam.com/2016-emerg
    ing-cancer-diagnostic-tests-and-strategic-profile-
    of-leading-reagent-and-instrument-suppliers-market
    /enquire-about-report

5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/2016-emerging-cancer-d
iagnostic-tests-and-strategic-profile-of-leading-r
eagent-and-instrument-suppliers-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com
Write a Comment
User Comments (0)
About PowerShow.com